LG-0250276

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameLG-0250276

Drug Alias NameLG-0250276

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionInterleukin-1 receptor-associated kinase 4 inhibitors

TargetsInterleukin-1 receptor-associated kinase 4

Therapy Area/IndicationsLymphoma, B-Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTg Therapeutics Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsLymphoma, B-Cell

Inactive IndicationsN/A

ATC CodeN/A